Richter Gedeon stock costs EUR 33.81 and yields 4.76 percent

Richter Gedeon stock (ISIN HU0000123096) was trading at EUR 33.81 at Lang & Schwarz on October 7, 2026 at 10:10 a.m. CEST, down 0.09 percent versus the prior close of EUR 33.84. The stock carried a 4.76 percent dividend yield on October 3, 2026, according to Onvista.

First-half growth broadens

Gedeon Richter's latest reported period is the first half of 2026. The company published its H1 2026 earnings presentation on August 7, 2026, according to its investor-relations page.

According to Yahoo Finance on August 7, 2026, constant-currency revenue grew 8.70 percent in the first half of 2026. Constant-currency Clean EBIT increased 21.00 percent, giving profitability a faster growth rate than revenue.

Guidance shifts to profit

Management also upgraded 2026 pharma Clean EBIT guidance to double-digit growth on a constant-currency basis, according to the same Yahoo Finance transcript. The comparison matters because the 21.00 percent first-half Clean EBIT increase already exceeded the 8.70 percent revenue growth rate.

The operating picture was mixed across business lines. Reagila sales in the company's own commercial territories grew 25.00 percent, while biotechnology revenue advanced 30.00 percent on a constant-currency basis in the first half of 2026. General medicines remained the weaker area, with management describing recovery as a 2027 objective.

Stock holds near EUR 34

At EUR 33.81, the Lang & Schwarz quote was EUR 0.03 below the October 6, 2026 prior close. The daily move was therefore limited to minus 0.09 percent, while the 4.76 percent dividend yield provides a separate valuation reference for income-oriented market participants.

The further course of trading is shown by the continuously updated real-time quote of Richter Gedeon stock.

More news and analyses on Richter Gedeon stock